Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01864304 · ClinicalTrials.gov registry record
Fat Distribution and Glucose Metabolism in Williams Syndrome
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 24
- Enrollment target
NCT01864304: Completed study, sponsored by Massachusetts General Hospital.
NCT01864304 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01864304 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
Williams Syndrome (WS) is a genetic syndrome with features that may include vascular stenoses, neuro-developmental changes, and a variety of endocrine and metabolic abnormalities, including impaired glucose metabolism and abnormal body composition. Approximately 75% of adults with WS have impaired glucose tolerance or diabetes on oral glucose tolerance testing (OGTT). In addition, clinical observations and preliminary data suggest increased overall body fat in these individuals, as well as a relative increase in fat deposition in the lower extremities. However, glucose and lipid metabolism in WS remain incompletely characterized. The purpose of the current study is to carefully describe glucose metabolism and lipid parameters in people with WS.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2013-12 |
| Est. Completion | 2016-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01864304
The ClinicalTrials.gov registry entry for NCT01864304 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01864304 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01864304 about?
NCT01864304 is a clinical study titled "Fat Distribution and Glucose Metabolism in Williams Syndrome". Williams Syndrome (WS) is a genetic syndrome with features that may include vascular stenoses, neuro-developmental changes, and a variety of endocrine and metabolic abnormalities, including impaired glucose metabolism and abnormal body composition. Approximately 75% of adults with WS have impaired g...
What is the current status of trial NCT01864304?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2013-12. Estimated completion is 2016-02.
Who is sponsoring clinical trial NCT01864304?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.